Covered recipient · General Payments record
SITARAMAIYER SESHADRI
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,942.54
- Reported across 159 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $592.40 | 36 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $283.15 | 22 |
| Janssen Biotech, Inc. | $148.80 | 3 |
| GENZYME CORPORATION | $78.24 | 3 |
| Amgen Inc. | $60.67 | 3 |
| UCB, Inc. | $43.41 | 2 |
| PFIZER INC. | $36.63 | 2 |
| Genentech USA, Inc. | $23.23 | 1 |
| Acerta Pharma LLC | $18.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.32 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058248 | CMS |
| ABBVIE INC. | $5.83 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058250 | CMS |
| ABBVIE INC. | $23.21 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058252 | CMS |
| ABBVIE INC. | $4.77 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058254 | CMS |
| ABBVIE INC. | $3.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058256 | CMS |
| ABBVIE INC. | $4.22 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058258 | CMS |
| ABBVIE INC. | $4.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058260 | CMS |
| ABBVIE INC. | $6.16 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058262 | CMS |
| ABBVIE INC. | $25.85 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058264 | CMS |
| ABBVIE INC. | $3.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058266 | CMS |
| ABBVIE INC. | $14.47 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058268 | CMS |
| ABBVIE INC. | $5.82 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058270 | CMS |
| ABBVIE INC. | $14.23 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058272 | CMS |
| ABBVIE INC. | $24.44 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058274 | CMS |
| ABBVIE INC. | $8.47 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058276 | CMS |
| ABBVIE INC. | $27.97 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058278 | CMS |
| ABBVIE INC. | $5.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058280 | CMS |
| ABBVIE INC. | $27.95 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058282 | CMS |
| ABBVIE INC. | $2.91 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058284 | CMS |
| ABBVIE INC. | $22.75 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058286 | CMS |
| ABBVIE INC. | $22.05 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058288 | CMS |
| ABBVIE INC. | $8.29 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058290 | CMS |
| Amgen Inc. | $22.05 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116103885 | CMS |
| Amgen Inc. | $25.36 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116103892 | CMS |
| Amgen Inc. | $13.26 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680098 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.26 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104596650 | CMS |
| Genentech USA, Inc. | $23.23 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133108086 | CMS |
| GENZYME CORPORATION | $22.37 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899028 | CMS |
| GENZYME CORPORATION | $27.15 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899102 | CMS |
| GENZYME CORPORATION | $28.72 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899114 | CMS |
| Janssen Biotech, Inc. | $24.72 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078479666 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/25/2024 | Education | Undisputed | 01/23/2026 | 1078479333 | CMS |
| Janssen Biotech, Inc. | $24.09 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078479869 | CMS |
| PFIZER INC. | $17.01 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131753440 | CMS |
| PFIZER INC. | $19.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848979 | CMS |
| UCB, Inc. | $21.76 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143142332 | CMS |
| UCB, Inc. | $21.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143142336 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.